"The Cancer Care Northwest South Spokane Clinic offers a complete range of integrated services, including PET/CT scans, chemotherapy treatment, surgical oncology, lab work and follow-up care. The clinic’s physicians specialize in medical hematology/oncology and surgical oncology, including one of the region’s best breast surgeons. The staff also includes a wide-variety of specialists that provide support services for patients. For four decades, cancer patients and their families have trusted Cancer Care Northwest as their partner in their fight against cancer. Why? Better All-Around, Compassionate Care Here, you get more than medical excellence. We are a place of healing, warmth and kindness."

During the past decade, Cancer Care Northwest - Spokane South conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 122 clinical trials were completed, i.e. on average, 938.5% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 36 clinical trials were completed. i.e. 1800% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cancer Care Northwest - Spokane South" #1 sponsor was "SWOG Cancer Research Network" with 90 trials, followed by "National Cancer Institute (NCI)" with 62 trials sponsored, "Alliance for Clinical Trials in Oncology" with 11 trials sponsored, "Radiation Therapy Oncology Group" with 10 trials sponsored and "US Oncology Research" with 10 trials sponsored. Other sponsors include 19 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cancer Care Northwest - Spokane South" #1 collaborator was "National Cancer Institute (NCI)" with 128 trials as a collaborator, "NRG Oncology" with 23 trials as a collaborator, "Cancer and Leukemia Group B" with 18 trials as a collaborator, "NCIC Clinical Trials Group" with 15 trials as a collaborator and "SWOG Cancer Research Network" with 12 trials as a collaborator. Other collaborators include 49 different institutions and companies that were collaborators in the rest 30 trials.

According to Clinical.Site data, the most researched conditions in "Cancer Care Northwest - Spokane South" are "Breast Cancer" (22 trials), "Lung Cancer" (17 trials), "Lymphoma" (15 trials), "Leukemia" (12 trials) and "Prostate Cancer" (8 trials). Many other conditions were trialed in "Cancer Care Northwest - Spokane South" in a lesser frequency.

Most popular intervention types in "Cancer Care Northwest - Spokane South" are "Drug" (172 trials), "Other" (84 trials), "Biological" (68 trials), "Radiation" (39 trials) and "Procedure" (26 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (51 trials), "Paclitaxel" (21 trials), "Quality-of-Life Assessment" (18 trials), "cyclophosphamide" (18 trials) and "Bevacizumab" (17 trials). Other intervention names were less common.

The vast majority of trials in "Cancer Care Northwest - Spokane South" are 152 trials for "All" genders, 45 trials for "Female" genders and 8 trials for "Male" genders.

Currently, there are NaN active trials in "Cancer Care Northwest - Spokane South". undefined are not yet recruiting, 5 are recruiting, 48 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 133 completed trials in Cancer Care Northwest - Spokane South, undefined suspended trials, and 17 terminated clinical trials to date.

Out of the total trials that were conducted in Cancer Care Northwest - Spokane South, 7 "Phase 1" clinical trials were conducted, 98 "Phase 2" clinical trials and 92 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".